Which closed-end funds own Kolon TissueGene, Inc.?
1 active closed-end fund report this security in their latest N-PORT filing, with a combined reported value of $2.4M. Security type: common equity. Country: United States. ISIN KR8840120008 · ticker 950160.KQ.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| KF Korea Fund | International Equity | 0.65% | $2.4M | 39,200 sh | $365M | 15.4% discount | Jun 30, 2026 |
1 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “950160.KQ” → · Compare two funds’ portfolios →